← Browse by Condition
Medical Condition

chronic heart failure

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for chronic heart failure sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chronic heart failure Clinical Trials

How many clinical trials are currently recruiting for chronic heart failure?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for chronic heart failure, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic heart failure?
chronic heart failure research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic heart failure clinical trial?
Eligibility criteria for chronic heart failure trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Semmelweis University Heart and Vascular Center 1 trial
Heartfelt Technologies 1 trial
Pr. Nicolas GIRERD 1 trial
Jens D Hove, MD,PHD 1 trial

Recruiting Clinical Trials

NCT07434193
Recruiting
Biventricular or Left Bundle Branch Pacing to Assess the Effect of Cardiac Resynchronization Therapy in Patients Undergoing Transcatheter Aortic Valve Implantation
Enrollment
360 pts
Location
Hungary
Sponsor
Semmelweis University Heart an...
View Trial →
NCT06222099
Recruiting
The HEARTFELT Study
Enrollment
1,500 pts
Location
United States
Sponsor
Heartfelt Technologies
View Trial →
NCT05089149
Recruiting
Chronic Heart Failure - COngestion eValuation
Enrollment
200 pts
Location
France
Sponsor
Pr. Nicolas GIRERD
View Trial →
NCT06423599 Phase 2, Phase 3
Recruiting
Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
Enrollment
100 pts
Location
Denmark
Sponsor
Jens D Hove, MD,PHD
View Trial →

Related Conditions

heart failure (1) heart failure with reduced ejection fraction (1) obesity (1) weight loss (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology